Ranking · Unmet Need
Research Gap Index
Burden percentile minus research-activity percentile (publications, last 5 years) within the same scope. Positive values flag cancers with high mortality burden but comparatively little literature. Caveat (Phase 1): literature counts are query-based per entity (query stored on each row); they are not aggregated over descendants.
Computedci-research-gap-v1unit: percentile pointshigher = worseAll metrics
| Rank | Δ | Cancer | Research Gap Index (percentile points) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Malignant Central Nervous System Neoplasm | +60 | 100 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596310 |
| 2 | = | Malignant Uterine Corpus Neoplasm | +36.7 | 96.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596311 |
| 3 | = | Malignant Colon Neoplasm | +23.4 | 93.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596312 |
| 4 | = | Malignant Kidney Neoplasm | +16.7 | 90 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596314 |
| 4 | = | Non-Hodgkin Lymphoma | +16.7 | 90 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596313 |
| 6 | = | Malignant Esophageal Neoplasm | +13.4 | 83.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596315 |
| 7 | = | Malignant Pancreatic Neoplasm | +13.3 | 80 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596316 |
| 8 | = | Malignant Liver Neoplasm | +10 | 76.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596318 |
| 8 | = | Malignant Salivary Gland Neoplasm | +10 | 76.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596317 |
| 10 | = | Malignant Laryngeal Neoplasm | +6.7 | 70 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596319 |
| 11 | = | Malignant Vulvar Neoplasm | +6.6 | 66.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596320 |
| 12 | = | Malignant Vaginal Neoplasm | +3.3 | 63.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596321 |
| 13 | = | Malignant Lung Neoplasm | +3.3 | 60 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596322 |
| 13 | = | Multiple Myeloma | +3.3 | 60 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596323 |
| 15 | = | Cutaneous Melanoma | 0 | 53.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596324 |
| 15 | = | Malignant Bladder Neoplasm | 0 | 53.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596325 |
| 17 | = | Malignant Nasopharyngeal Neoplasm | -3.3 | 46.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596326 |
| 18 | = | Leukemia | -3.4 | 43.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596327 |
| 18 | = | Malignant Mesothelioma | -3.4 | 43.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596328 |
| 20 | = | Malignant Prostate Neoplasm | -6.6 | 36.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596329 |
| 21 | = | Malignant Breast Neoplasm | -6.7 | 33.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596330 |
| 21 | = | Malignant Ovarian Neoplasm | -6.7 | 33.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596331 |
| 21 | = | Malignant Rectal Neoplasm | -6.7 | 33.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596332 |
| 24 | = | Malignant Hypopharyngeal Neoplasm | -10 | 23.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596333 |
| 25 | = | Hodgkin Lymphoma | -13.3 | 20 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596334 |
| 26 | = | Malignant Anal Neoplasm | -13.4 | 16.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596335 |
| 27 | = | Malignant Penile Neoplasm | -23.3 | 13.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596336 |
| 27 | = | Malignant Testicular Neoplasm | -23.3 | 13.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596337 |
| 29 | = | Malignant Thyroid Gland Neoplasm | -30 | 6.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596338 |
| 30 | = | Malignant Gastric Neoplasm | -33.3 | 3.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596339 |
| 31 | = | Malignant Cervical Neoplasm | -40 | 0 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2596340 |
Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 534df28088994df28ee34af5